Paul Bertin is a co-founder and PhD candidate at Mila specializing in machine learning for drug discovery, with nine years of experience bridging academic research and startup execution. He leads development of lab-in-the-loop methods for guiding drug combination screens that were prospectively validated on cancer cell lines and now focuses on genome-scale structured models of cell dynamics from single-cell transcriptomics. His background spans top French institutions (École Polytechnique, ENS Paris-Saclay) and international research internships, blending rigorous applied mathematics with deep learning. Based in Montreal, he translates mechanistic biological questions into scalable ML models and experimental pipelines, uniquely combining hands-on assay validation with theoretical model design.
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.